Insider Trading activities of Codexis Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Codexis Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Codexis Inc since year 2005. Table 2 shows the detailed insider transactions of Codexis Inc since 2005. The reporting company's ticker symbol is CDXS. The reporting company's CIK number is 1200375.
The total value of stock buying since 2005 is $885,306.
The total value of stock sales since 2005 is $30,287,075.
The total value of stock option exercises since 2005 is $2,929,407.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Codexis Inc (CDXS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-10 0 $0 80,000 $1,351,400 80,000 $1,355,000
2018-09 0 $0 239,089 $4,309,476 80,000 $276,800
2018-08 0 $0 236,667 $3,510,068 67,591 $562,781
2018-07 0 $0 85,000 $1,312,195 0 $0
2018-06 0 $0 62,160 $938,460 9,007 $31,164
2018-05 0 $0 121,951 $1,659,588 44,000 $192,280
2018-04 0 $0 6,000 $62,214 0 $0
2018-03 0 $0 99,337 $1,125,227 39,131 $202,056
2017-09 0 $0 1,060,000 $6,121,500 0 $0
2017-01 0 $0 0 $0 6,666 $16,331
2016-11 10,000 $48,300 0 $0 0 $0
2016-09 0 $0 111,600 $474,634 0 $0
2016-08 0 $0 197,537 $836,029 21,666 $53,081
2015-11 0 $0 9,441 $33,235 26,666 $27,998
2015-09 10,000 $34,710 5,200 $17,966 16,666 $17,499
2015-08 40,000 $157,600 0 $0 0 $0
2015-06 0 $0 35,416 $145,276 0 $0
2014-11 40,000 $93,800 2,921,225 $6,923,303 0 $0
2014-08 60,000 $133,200 0 $0 0 $0
2014-07 0 $0 0 $0 27,350 $18,598
2013-05 0 $0 0 $0 3,033 $1,819
2013-03 91,000 $205,250 0 $0 0 $0
2012-11 5,000 $11,000 0 $0 0 $0
2012-09 5,000 $13,875 7,600 $20,979 0 $0
2011-12 0 $0 91,666 $483,518 0 $0
2011-07 0 $0 15,000 $151,878 15,000 $9,000
2011-06 0 $0 15,000 $155,814 15,000 $9,000
2011-05 2,000 $19,002 15,000 $156,660 115,000 $69,000
2011-04 0 $0 15,000 $181,020 15,000 $9,000
2011-03 0 $0 15,000 $159,735 65,000 $39,000
2011-02 0 $0 15,000 $156,900 15,000 $9,000
2010-08 21,500 $168,569 0 $0 0 $0
2010-05 0 $0 0 $0 50,000 $30,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Codexis Inc insiders (CDXS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-10-03 Sangster Gordon (SVP & Chief Financial Officer) Sale 40,000 17.02 680,920
2018-10-03 Sangster Gordon (SVP & Chief Financial Officer) Option Ex 40,000 17.11 684,520
2018-10-02 Sangster Gordon (SVP & Chief Financial Officer) Sale 40,000 16.76 670,480
2018-10-02 Sangster Gordon (SVP & Chief Financial Officer) Option Ex 40,000 16.76 670,480
2018-09-28 Nicols John J (President and CEO) Sale 40,000 17.43 697,320
2018-09-28 Nicols John J (President and CEO) Option Ex 40,000 3.46 138,400
2018-09-27 Nicols John J (President and CEO) Sale 40,000 18.09 723,520
2018-09-27 Nicols John J (President and CEO) Option Ex 40,000 3.46 138,400
2018-09-27 Baruch Thomas R Sale 12,500 18.25 228,100
2018-09-26 Wolf Dennis P Sale 9,000 19.17 172,521
2018-09-26 Baruch Thomas R Sale 12,500 19.00 237,487
2018-09-25 Glaub Kathleen Sereda Sale 14,492 18.82 272,811
2018-09-21 Kelley Bernard J Sale 10,207 18.12 184,961
2018-09-19 Glaub Kathleen Sereda Sale 20,094 17.93 360,385
2018-09-19 Yang Patrick Y Sale 25,000 17.94 448,425
2018-09-18 Yang Patrick Y Sale 25,000 18.47 461,750
2018-09-05 Lalonde James (SVP, R&D) Sale 12,381 17.35 214,847
2018-09-04 Lalonde James (SVP, R&D) Sale 17,915 17.16 307,349
2018-08-30 Kelley Bernard J Sale 16,666 17.15 285,788
2018-08-30 Kelley Bernard J Option Ex 16,666 7.46 124,328
2018-08-21 Sangster Gordon (SVP & Chief Financial Officer) Sale 18,736 15.31 286,904
2018-08-20 Wolf Dennis P Sale 18,333 15.24 279,413
2018-08-20 Wolf Dennis P Option Ex 18,333 10.51 192,679
2018-08-17 Wolf Dennis P Sale 18,333 14.71 269,605
2018-08-17 Wolf Dennis P Option Ex 18,333 10.71 196,438
2018-08-16 Yang Patrick Y Sale 150,340 14.45 2,172,413
2018-08-15 Nicols John J (President and CEO) Sale 2,400 14.90 35,760
2018-08-15 Nicols John J (President and CEO) Option Ex 2,400 3.46 8,304
2018-08-14 Nicols John J (President and CEO) Sale 11,859 15.19 180,185
2018-08-14 Nicols John J (President and CEO) Option Ex 11,859 3.46 41,032
2018-07-19 Yang Patrick Y Sale 25,000 15.52 387,975
2018-07-18 Glaub Kathleen Sereda Sale 10,000 15.34 153,400
2018-07-18 Yang Patrick Y Sale 25,000 15.40 384,925
2018-07-17 Lalonde James (SVP, R&D) Sale 7,500 15.27 114,555
2018-07-16 Lalonde James (SVP, R&D) Sale 7,500 15.53 116,460
2018-07-16 Dorgan Byron L Sale 10,000 15.49 154,880
2018-06-26 Wolf Dennis P Sale 9,000 14.47 130,212
2018-06-26 Baruch Thomas R Sale 12,500 14.38 179,775
2018-06-25 Baruch Thomas R Sale 12,500 15.48 193,550
2018-06-21 Kelley Bernard J Sale 10,206 16.58 169,256
2018-06-12 Wolf Dennis P Sale 8,947 14.41 128,971
2018-06-11 Nicols John J (President and CEO) Sale 1,800 14.47 26,055
2018-06-11 Nicols John J (President and CEO) Option Ex 1,800 3.46 6,228
2018-06-08 Nicols John J (President and CEO) Sale 7,207 15.35 110,641
2018-06-08 Nicols John J (President and CEO) Option Ex 7,207 3.46 24,936
2018-05-24 Sangster Gordon (SVP & Chief Financial Officer) Sale 18,736 14.11 264,308
2018-05-22 Cheng Pam P. Sale 19,607 14.17 277,772
2018-05-21 Cheng Pam P. Sale 19,608 14.06 275,766
2018-05-17 Aldridge Michael D. (See Remarks) Sale 22,000 13.54 297,858
2018-05-17 Aldridge Michael D. (See Remarks) Option Ex 22,000 4.37 96,140
2018-05-15 Aldridge Michael D. (See Remarks) Sale 22,000 12.91 283,954
2018-05-15 Aldridge Michael D. (See Remarks) Option Ex 22,000 4.37 96,140
2018-05-15 Lalonde James (SVP, R&D) Sale 10,000 12.90 129,030
2018-05-14 Lalonde James (SVP, R&D) Sale 10,000 13.09 130,900
2018-04-03 Smith David V Sale 6,000 10.37 62,214
2018-03-29 Baruch Thomas R Sale 12,500 11.06 138,200
2018-03-28 Baruch Thomas R Sale 12,500 11.05 138,125
2018-03-27 Wolf Dennis P Sale 12,500 11.14 139,300
2018-03-26 Wolf Dennis P Sale 29,166 11.15 325,084
2018-03-26 Wolf Dennis P Option Ex 16,666 7.46 124,328
2018-03-23 Nicols John J (President and CEO) Sale 16,154 11.43 184,656
2018-03-23 Nicols John J (President and CEO) Option Ex 16,154 3.46 55,892
2018-03-22 Nicols John J (President and CEO) Sale 6,311 11.91 75,176
2018-03-22 Nicols John J (President and CEO) Option Ex 6,311 3.46 21,836
2018-03-21 Kelley Bernard J Sale 10,206 12.22 124,686
2017-09-14 Vivo Ventures Vii, Llc Sale 1,060,000 5.78 6,121,500
2017-01-05 Lalonde James (SVP, R&D) Option Ex 6,666 2.45 16,331
2016-11-15 Yang Patrick Y Buy 10,000 4.83 48,300
2016-09-08 Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) Sale 111,600 4.25 474,634
2016-08-29 Wolf Dennis P Sale 9,000 4.19 37,683
2016-08-26 Wolf Dennis P Sale 9,000 4.25 38,285
2016-08-24 Kelley Bernard J Sale 12,643 4.26 53,808
2016-08-24 Kelley Bernard J Option Ex 21,666 2.45 53,081
2016-08-16 Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) Sale 36,894 4.21 155,213
2016-08-15 Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) Sale 50,000 4.27 213,700
2016-08-04 Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) Sale 50,000 4.17 208,400
2016-08-03 Vivo Ventures Vii Affiliates Fund, L.p. (10% Owner) Sale 30,000 4.30 128,940
2015-11-11 Lalonde James (SVP, R&D) Sale 5,805 3.52 20,433
2015-11-11 Lalonde James (SVP, R&D) Option Ex 16,391 1.05 17,210
2015-11-10 Lalonde James (SVP, R&D) Sale 3,636 3.52 12,802
2015-11-10 Lalonde James (SVP, R&D) Option Ex 10,275 1.05 10,788
2015-09-11 Yang Patrick Y Buy 10,000 3.47 34,710
2015-09-10 Kelley Bernard J Sale 5,200 3.46 17,966
2015-09-10 Kelley Bernard J Option Ex 16,666 1.05 17,499
2015-08-24 Yang Patrick Y Buy 10,000 3.83 38,350
2015-08-21 Yang Patrick Y Buy 10,000 3.98 39,770
2015-08-14 Yang Patrick Y Buy 20,000 3.97 79,480
2015-06-15 Wolf Dennis P Sale 17,708 4.08 72,160
2015-06-12 Wolf Dennis P Sale 17,708 4.13 73,116
2014-11-18 Yang Patrick Y Buy 20,000 2.35 47,000
2014-11-17 Yang Patrick Y Buy 20,000 2.34 46,800
2014-11-10 Handelsman Karl D. (10% Owner) Sale 2,921,225 2.37 6,923,303
2014-08-12 Yang Patrick Y Buy 60,000 2.22 133,200
2014-07-01 Lalonde James (SVP, R&D) Option Ex 27,350 .68 18,598
2013-05-16 Tobin Matthew (SVP, Research & Development) Option Ex 3,033 .60 1,819
2013-03-08 Nicols John J (President & CEO) Buy 27,000 2.42 65,394
2013-03-07 Nicols John J (President & CEO) Buy 27,000 2.27 61,371
2013-03-06 Nicols John J (President & CEO) Buy 27,000 2.16 58,266
2013-03-04 O'toole David D (SVP & Chief Financial Officer) Buy 10,000 2.02 20,219
2012-11-12 O'toole David D (SVP & Chief Financial Officer) Buy 5,000 2.20 11,000
2012-09-14 O'toole David D (SVP & Chief Financial Officer) Buy 2,500 2.85 7,125
2012-09-14 Sheehy Douglas T. (SVP, General Counsel & Sec.) Sale 3,800 2.76 10,499
2012-09-14 Anton David L. (SVP, BioIndustrials) Sale 3,800 2.76 10,480
2012-09-13 O'toole David D (SVP & Chief Financial Officer) Buy 2,500 2.70 6,750
2011-12-16 Shaw Alan (President and CEO) Sale 23,846 5.25 125,239
2011-12-15 Shaw Alan (President and CEO) Sale 30,000 5.30 158,880
2011-12-14 Shaw Alan (President and CEO) Sale 30,000 5.26 157,680
2011-12-13 Shaw Alan (President and CEO) Sale 7,820 5.33 41,719
2011-07-07 Shaw Alan (President and CEO) Sale 13,750 10.14 139,370
2011-07-07 Shaw Alan (President and CEO) Option Ex 13,750 .60 8,250
2011-07-06 Shaw Alan (President and CEO) Sale 1,250 10.01 12,508
2011-07-06 Shaw Alan (President and CEO) Option Ex 1,250 .60 750
2011-06-02 Shaw Alan (President and CEO) Sale 9,600 10.37 99,590
2011-06-02 Shaw Alan (President and CEO) Option Ex 9,600 .60 5,760
2011-06-01 Shaw Alan (President and CEO) Sale 5,400 10.41 56,224
2011-06-01 Shaw Alan (President and CEO) Option Ex 5,400 .60 3,240
2011-05-18 Shaw Alan (President and CEO) Option Ex 50,000 .60 30,000
2011-05-11 Lawson Robert J (SVP and CFO) Buy 2,000 9.50 19,002
2011-05-10 Shaw Alan (President and CEO) Option Ex 50,000 .60 30,000
2011-05-02 Shaw Alan (President and CEO) Sale 15,000 10.44 156,660
2011-05-02 Shaw Alan (President and CEO) Option Ex 15,000 .60 9,000
2011-04-01 Shaw Alan (President and CEO) Sale 15,000 12.07 181,020
2011-04-01 Shaw Alan (President and CEO) Option Ex 15,000 .60 9,000
2011-03-07 Shaw Alan (President and CEO) Option Ex 50,000 .60 30,000
2011-03-01 Shaw Alan (President and CEO) Sale 15,000 10.65 159,735
2011-03-01 Shaw Alan (President and CEO) Option Ex 15,000 .60 9,000
2011-02-11 Shaw Alan (President and CEO) Sale 15,000 10.46 156,900
2011-02-11 Shaw Alan (President and CEO) Option Ex 15,000 .60 9,000
2010-08-27 Baruch Thomas R (Director) Buy 2,500 7.55 18,865
2010-08-24 Pasternack Bruce A (Director) Buy 3,700 7.56 27,972
2010-08-23 Pasternack Bruce A (Director) Buy 4,000 7.88 31,500
2010-08-12 Pasternack Bruce A (Director) Buy 2,300 7.96 18,296
2010-08-10 Sheehy Douglas T. (SVP, Gen Counsel and Sec.) Buy 1,000 7.99 7,986
2010-08-10 Sarret Joseph J. (CBO, President Pharmaceuticals) Buy 2,000 7.99 15,978
2010-08-10 Anton David L. (SVP, Research and Development) Buy 2,000 7.99 15,986
2010-08-10 Lawson Robert J (SVP and CFO) Buy 2,000 8.00 15,992
2010-08-10 Shaw Alan (President and CEO) Buy 2,000 8.00 15,994
2010-05-12 Shaw Alan (President and CEO) Option Ex 50,000 .60 30,000

Insider trading activities including stock purchases, stock sales, and option exercises of CDXS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Codexis Inc (symbol CDXS, CIK number 1200375) see the Securities and Exchange Commission (SEC) website.